Failure of Somatostatin Analogue Sms 201–995 to Control Cushing's Syndrome Due to Ectopic Release of Acth from a Bronchial Carcinoid
- 1 October 1989
- journal article
- case report
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 34 (5) , 533-534
- https://doi.org/10.1177/003693308903400510
Abstract
A patient with ectopic Cushing's syndrome secondary to a malignant thymic carcinoid tumour was treated with the somatostatin analogue SMS 201–995. The administration of the drug subcutaneously in increasing doses over a 34 day period failed to control the ACTH or glucocorticoid excess.Keywords
This publication has 14 references indexed in Scilit:
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Visual Improvement with SMS 201–995 in a Patient with a Thyrotropin-Secreting Pituitary AdenomaNew England Journal of Medicine, 1987
- Chemotherapy of metastatic carcinoid and islet cell tumors: A reviewThe American Journal of Medicine, 1987
- Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndromeCancer, 1987
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Rapid Reversal of Carcinoid Crisis with a Somatostatin AnalogueNew England Journal of Medicine, 1985
- Malignant Insulinoma: Effects of a Somatostatin Analog (Compound 201-995) on Serum Glucose, Growth, and Gastro-Entero-Pancreatic HormonesAnnals of Internal Medicine, 1985
- Long-Term Treatment of a VIPoma With Somatostatin Analogue Resulting in Remission of Symptoms and Possible Shrinkage of MetastasesGastroenterology, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984